Concepedia

Rebekka Bitsch

RB

Statistics

Publications

5

Citations

194

H-Index

5

Active since

2022

Affiliations

University Hospital Heidelberg(Current)

Heidelberg University

University Medical Centre Mannheim

German Cancer Research Center

Rebekka Bitsch is an author at University Hospital Heidelberg specializing in oncology, tumor immunity, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2022–2023

5

Publications

5

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice

Rebekka Bitsch, Annina Kurzay, Feyza Gül Özbay Kurt et al. · Journal for ImmunoTherapy of Cancer · 2022 · 81 citations · Full text

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards et al. · Frontiers in Immunology · 2022 · 43 citations · Full text

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling

Ihor Arkhypov, Feyza Gül Özbay Kurt, Rebekka Bitsch et al. · Journal for ImmunoTherapy of Cancer · 2022 · 35 citations · Full text

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients

Vera Petrova, Christopher Groth, Rebekka Bitsch et al. · Frontiers in Immunology · 2023 · 19 citations · Full text

, , +17

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs

Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt et al. · OncoImmunology · 2023 · 16 citations · Full text

1–5 of 5